(2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 1g

3-methyl-2,4-dihydro-1H-indazol-4-one, 98%, 1g

Palladiumdraht 99,95 % 0,5 mm Durchmesser 2,5 m

(2E)-3-[4-(benzyloxy)phenyl]-1-{[1,1'-biphenyl]-4-yl}prop-2-en-1-one, 95.0%, 2g

Sulfamic acid, [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-[(trifluoromethyl)thio]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl ester, 100mg

4-Chloro-2-methylbenzoic acid, 98.0%, 100g

Ampullen, vorgeritzt, 10 ml, Klarglas, Ø 19 x 107, 144 Stück

(6-(4-(tert-Butoxycarbonyl)piperazin-1-yl)-5-methylpyridin-3-yl)boronic acid, 95.0%, 250mg

1-Phenylethanamine, 95.0%, 25g

3-Acetyl-1-[(4-nitrophenyl)methyl]pyridin-1-ium bromide, 250mg

(S)-2-((tert-Butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 95.0%, 250mg

7-(4-chlorobutoxy)-3,4-dihydro-1H-quinolin-2-one, 97%, 1g

(R)-2-Phenylpyrrolidine hydrochloride, 95.0%, 250mg